Related Experiment Video

Updated: Jun 3, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Non-small cell lung cancer in never-smokers: a new disease entity?

David F Heigener1

  • 1Department of Thoracic Oncology, Krankenhaus Grosshansdorf, Germany. d.heigener@kh-grosshansdorf.de

Onkologie
|March 31, 2011
PubMed

Insights

Non-small cell lung cancer (NSCLC) in never-smokers is rising, with unique biology favoring targeted therapies. Research highlights two key targets and recent treatment advancements for this specific patient group.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Non-small cell lung cancer (NSCLC) in never-smokers represents a growing clinical challenge.
  • This NSCLC subtype may possess distinct pathogenetic mechanisms compared to smokers.
  • These differences suggest a potential for increased sensitivity to targeted therapeutic agents.

Purpose of the Study:

  • To provide an overview of the biological underpinnings of NSCLC in never-smokers.
  • To review the latest therapeutic developments for this specific NSCLC population.
  • To highlight identified promising molecular targets for treatment.

Main Methods:

  • Literature review of recent studies on NSCLC in never-smokers.
  • Analysis of biological pathways and genetic alterations.
  • Synthesis of data on targeted therapies and clinical trial outcomes.

Main Results:

  • Identification of distinct biological characteristics in NSCLC among never-smokers.
  • Confirmation of increased sensitivity to certain targeted therapies in this cohort.
  • Two specific molecular targets have emerged as promising avenues for treatment.

Conclusions:

  • NSCLC in never-smokers is a biologically unique entity.
  • Targeted therapies represent a significant advancement in treating this population.
  • Further research into these targets may yield more effective treatment strategies.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...